Benzinga's Top Upgrades, Downgrades For December 1, 2017

Loading...
Loading...

Top Upgrades

  • Analysts at Goldman Sachs upgraded AGCO Corporation AGCO from Neutral to Buy. AGCO shares fell 0.17 percent to close at $70.78 on Thursday.
  • Longbow Research upgraded Mellanox Technologies, Ltd. MLNX from Neutral to Buy. Mellanox Technologies shares rose 2.78 percent to close at $59.10 on Thursday.
  • Wedbush upgraded Vantiv Inc VNTV from Neutral to Outperform. Vantiv shares fell 0.67 percent to $74.50 in pre-market trading.
  • Analysts at KeyBanc upgraded Tiffany & Co. TIF from Sector Weight to Overweight. Tiffany shares rose 2.13 percent to close at $94.50 on Wednesday.
  • Morgan Stanley upgraded Novo Nordisk A/S (ADR) NVO from Equal-Weight to Overweight. Novo Nordisk shares gained 1.24 percent to $52.41 in pre-market trading.
  • Analysts at BMO Capital upgraded VMware, Inc. VMW from Market Perform to Outperform. VMware shares rose 1.78 percent to $122.25 in pre-market trading.
  • Wells Fargo upgraded Stifel Financial Corp SF from Market Perform to Outperform. Stifel Financial shares rose 1.21 percent to close at $56.24 on Thursday.
  • Gabelli upgraded Melinta Therapeutics, Inc. MLNT from Sell to Hold. Melinta Therapeutics shares rose 11.84 percent to close at $17.00 on Thursday.


Top Downgrades

  • Citigroup downgraded Regeneron Pharmaceuticals Inc REGN from Buy to Neutral. Regeneron Pharmaceuticals shares fell 1.90 percent to $355.00 in pre-market trading.
  • Analysts at Goldman Sachs downgraded Cummins Inc. CMI from Buy to Neutral Cummins shares fell 1.08 percent to $165.60 in pre-market trading.
  • Argus downgraded Priceline Group Inc PCLN from Buy to Hold. Priceline shares fell 0.73 percent to $1,727.00 in pre-market trading.
  • Mizuho Securities downgraded PG&E Corporation PCG from Buy to Neutral. PG&E shares slipped 1.49 percent to close at $54.24 on Thursday.
  • Morgan Stanley downgraded Sanofi SA (ADR) SNY from Overweight to Underweight. Sanofi-Aventis shares fell 2.54 percent to $44.48 in pre-market trading.
  • Needham & Company downgraded Oxford Industries Inc OXM from Buy to Hold. Oxford Industries shares fell 1.22 percent to close at $69.00 on Thursday.
  • Analysts at SunTrust Robinson Humphrey downgraded Cypress Semiconductor Corporation CY from Buy to Hold. Cypress Semi shares fell 2.12 percent to $15.67 in pre-market trading.


Top Initiations

  • Stifel Nicolaus initiated coverage on DDR Corp DDR with a Hold rating. The price target for DDR is set to $8.25. DDR shares closed at $7.63 on Thursday.
  • H.C. Wainwright initiated coverage on Sarepta Therapeutics Inc SRPT with a Buy rating. The price target for Sarepta Therapeutics is set to $75. Sarepta Therapeutics shares closed at $55.67 on Thursday.
  • H.C. Wainwright initiated coverage on Global Blood Therapeutics Inc GBT with a Buy rating. The price target for Global Blood Therapeutics is set to $73. Global Blood Therapeutics shares closed at $39.45 on Thursday.
  • Analysts at Canaccord Genuity initiated coverage on Plug Power Inc PLUG with a Buy rating. The price target for Plug Power is set to $5. Plug Power shares closed at $2.37 on Thursday.
  • Citigroup initiated coverage on Diamondback Energy Inc FANG with a Buy rating. The price target for Diamondback Energy is set to $130. Diamondback Energy shares closed at $109.31 on Thursday.
  • Analysts at H.C. Wainwright initiated coverage on Uniqure NV QURE with a Buy rating. The price target for Uniqure is set to $28. Uniqure shares closed at $15.14 on Thursday.
  • Analysts at SunTrust Robinson Humphrey initiated coverage on Booz Allen Hamilton Holding Corporation BAH with a Buy rating. The price target for Booz Allen is set to $47. Booz Allen shares closed at $38.69 on Thursday.
Loading...
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: UpgradesDowngradesInitiationPre-Market OutlookAnalyst RatingsDowngradesInitiationstop upgrades
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...